Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Avanos Medical (AVNS) Equity Ratio (2016 - 2025)

Avanos Medical's Equity Ratio history spans 11 years, with the latest figure at 0.74 for Q3 2024.

  • For Q3 2024, Equity Ratio rose 4.8% year-over-year to 0.74; the TTM value through Sep 2024 reached 0.74, up 4.8%, while the annual FY2023 figure was 0.73, 1.09% up from the prior year.
  • Equity Ratio for Q3 2024 was 0.74 at Avanos Medical, up from 0.19 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.79 in Q3 2021 and bottomed at 0.19 in Q2 2024.
  • The 5-year median for Equity Ratio is 0.71 (2022), against an average of 0.39.
  • The largest annual shift saw Equity Ratio skyrocketed 14859.15% in 2021 before it crashed 347.78% in 2024.
  • A 5-year view of Equity Ratio shows it stood at 0.75 in 2020, then rose by 5.02% to 0.79 in 2021, then fell by 8.8% to 0.72 in 2022, then grew by 1.09% to 0.73 in 2023, then rose by 1.64% to 0.74 in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Equity Ratio are 0.74 (Q3 2024), 0.19 (Q2 2024), and 0.02 (Q1 2024).